Expression level of c-FLIP versus Fas determines susceptibility to Fas ligand-induced cell death in murine thymoma EL-4 cells

Experimental Cell Research

Volumn 273, Issue 2, 2002, Pages 256-264

  Kataoka, Takao ^a   Ito, Mika ^a   Budd, Ralph C ^b   Tschopp, Jürg ^c   Nagai, Kazuo ^a  

^a TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Apoptosis; c FLIP; DNA damage; Fas CD95; p53

Indexed keywords

APOPTOSIS INHIBITOR; CASPASE INHIBITOR; CYCLOHEXIMIDE; FAS ANTIGEN; FAS LIGAND; FLICE INHIBITORY PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL SURFACE; CONTROLLED STUDY; DNA DAMAGE; GENETIC TRANSFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SENSITIZATION;

MURINAE;

EID: 0036060976     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2001.5438     Document Type: Article

References (34)

1. Death receptors: Signaling and modulation
2. Apoptosis by death factor
3. Autoimmunity as a consequence of retrovirus-mediated expression of c-FLIP in lymphocytes
4. Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein
5. The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors
6. Caspase activation: The induced-proximity model
7. Inhibition of death receptor signals by cellular FLIP
8. Inhibition of Fas death signals by FLIPs
9. L and adenovirus protein E1B 19kD are functionally equivalent in their ability to inhibit cell death
10. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen
11. Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes
12. L and resistance to CD95-mediated apoptosis of monocyte-derived dendritic cells: Inhibition by bisindolylmaleimide
13. Inhibition of death receptor-mediated gene induction by a cycloheximide-sensitive factor occurs at the level or upstream of Fas-associated death domain protein (FADD)
14. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression
15. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs
16. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
17. Bcl-2 inhibits a Fas-induced conformational change in the Bax N terminus and Bax mitochondrial translocation
18. The role of c-FLIP in modulation of CD95-induced apoptosis
19. The caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways
20. NF-κB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling
21. NF-κB signals induce the expression of c-FLIP
22. FLICE-inhibitory protein expression during macrophage differentiation confers resistance to Fas-mediated apoptosis
23. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis
24. Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis
25. Mitogen-activated protein kinase kinase antagonized Fas-associated death domain protein-mediated apoptosis by induced FLICE-inhibitory protein expression
26. Inhibition of Fas-mediated apoptosis by the B cell antigen receptor through c-FLIP
27. Enhanced expression of Fas-associated death domain-like IL-1-converting enzyme (FLICE)-inhibitory protein induces resistance to Fas-mediated apoptosis in activated mast cells
28. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis
29. Ionizing radiation and chemotherapeutic drugs induce apoptosis in lymphocytes in the absence of Fas or FADD/MORT1 signaling: Implications for cancer therapy
30. CD95 (Fas/APO-1) and p53 signal apoptosis independently in diverse cell types
31. Human and mouse Fas (APO-1/CD95) death receptor genes each contain a p53-responsive element that is activated by p53 mutants unable to induce apoptosis
32. Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells
33. FLIP prevents apoptosis induced by death receptors but not by perforin/granzyme B, chemotherapeutic drugs, and gamma irradiation
34. Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development